Alpha Crest Capital Management LLC Shockwave Medical, Inc. Transaction History

Alpha Crest Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$195.21 - $310.53 $41,579 - $66,142	-213 Reduced 14.53%	1,253 $348,000
Q2 2022 Aug 11, 2022	SELL	$115.91 - $214.48 $200,408 - $370,835	-1,729 Reduced 54.12%	1,466 $280,000
Q1 2022 May 12, 2022	SELL	$127.96 - $207.36 $10,876 - $17,625	-85 Reduced 2.59%	3,195 $663,000
Q4 2021 Feb 09, 2022	SELL	$165.13 - $241.83 $141,186 - $206,764	-855 Reduced 20.68%	3,280 $585,000
Q3 2021 Nov 10, 2021	BUY	$163.99 - $235.57 $678,098 - $974,081	4,135 New	4,135 $851,000
Q1 2021 May 13, 2021	SELL	$92.73 - $142.05 $510,015 - $781,275	-5,500 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$67.44 - $103.72 $148,368 - $228,184	2,200 Added 66.67%	5,500 $570,000
Q3 2020 Nov 12, 2020	BUY	$42.79 - $75.8 $141,207 - $250,140	3,300 New	3,300 $250,000

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.